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Abstract 
The dithiocarbamates are a group of compounds that 
are used extensively in industry, agriculture and medi-
cine. Exposure to these compounds has caused deleteri-
ous effects to both the central and peripheral nervous 
systems. Cultured rat hippocampal astroglia treated with 
35 µglml diethyldithiocarbamate (DDC) in media were 
studied for alterations to the cytoskeleton. Examination 
by both immunohistochemistry and scanning electron 
microscopy revealed disruption of the cytoskeletal ele-
ments. This occurred in a progressive time-dependent 
manner. Electrophoretic patterns demonstrated two 
cytoskeletal protein alterations . The microtubular pro-
tein, {3-tubulin, appeared to have an altered mobility 
while the major intermediate filament protein , glial fi-
brillary acidic protein (GF AP), was decreased. The 
cytoskeleton appears to be an important cellular target 
for injury by DDC exposure. This study has demon-
strated that DDC induces alterations in the architecture 
of the cytoskeleton of astroglia and suggests that these 
changes involve microtubular and intermediate filament 
proteins. 
Key Words: Astrocyte, carbamates, cytoskeleton, di-
ethyldithiocarbamate, DDC, glial fibrillary acidic pro-
tein, intermediate filaments, microtubule s, neurotoxicity , 
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Introduction 
The nervous system is a rich source of cytoskeletal 
proteins that assume critical roles in determining and 
maintaining the integrity of nervous tissue structure and 
function. Many of the neurodegenerative diseases are 
characterized by alterations to filamentous proteins 
resulting in compromised cellular function or cell death . 
Alterations in cytoskeletal architecture have also been as-
sociated with aging processes (Goldman and Yen, 1986). 
The abnormalities of cytoskeletal structure seen in many 
neurotoxic and neurodegenerative diseases include ab-
normal cross-linking, oxidation of essential membrane or 
protein sulfhydryl groups, lipid peroxidative injury and 
altered calcium homeostasis (Marcum et al ., 1978; 
Lehto et al., 1984; Li et al. , 1987; Li and Chou, 1992). 
Neurotoxic substances are often associated with the 
pathogenesis of the cytoskeleton. Profoundly abnormal 
arrangements and distortions of cytoskeletal elements 
have been described within neuronal and glial cells 
(Ghetti, 1979; Griffin et al., 1983). The experimental 
disruption of cytoskeletal elements contributes to the 
understanding of the pathogenesis of both toxic and 
degenerative alterations . 
This paper addresses the problem of neurotoxic 
injury to the cytoskeleton produced by exposure to the 
dithiocarbamates, specifically diethyldithiocarbamate 
(DDC). The dithiocarbamates have had extensive appli-
cations in industry, agriculture, and medicine (Cohen 
and Robins, 1990). They are extremely reactive com-
pounds due to their metal-chelating characteristics, inter-
actions with sulfhydryl groups and enhancement of oxi-
dative reactions. These compounds are known inhibitors 
of many metal-dependent and sulfhydryl enzyme systems 
(Miller, 1982). 
The dithiocarbamates have been shown to induce 
degenerative changes in both the central and peripheral 
nervous systems (Adachi and Solitaire, 1979; Anzil, 
1985). Observations, in a rat model, by transmission 
electron microscopy, at the earliest stages of insult, 
show large numbers of microtubules and neurofilaments 
in various stages of degeneration (Ansbacher et al., 
Mary F. McManu s and Louis D. Trombetta 
1982; Trombetta and Adachi, 1985). Early degenerativ e 
changes were noted in astroglial cells months prior to 
neuronal damage, suggesting that the astrocyte may be 
the initial target for DOC-induced injury (Trombetta and 
Adachi , 1985). 
DDC is a sulfhydryl-containingchelator that is capa-
ble of forming a bis-(DDC)-metal ;:omplex (Johansson 
and Stankiewicz , 1985). Because of it's highly lipo-
philic character, this complex can readily pass through 
membrane barriers, resulting in an observable increase 
in intracellular metal concentration (Johansson and 
Stankiewicz, 1985; Andersen et al., 1988). The cyto-
toxic action may be mediated by the chelating propertie s 
of the compound, resulting in inhibitory effects on a va-
riety of cellular functions (Tempel et al., 1985), or by 
the formation of disulfide linkages with essential proteins 
(Stromme, 1963). This affinity offers some clinical ap-
plication in the treatment of metal toxicity (YI eiss et al., 
1990) and has aiso been used to ameiiorate the nephro-
toxic effects of the antineoplastic agent cisplatin (Borch 
and Pleasants, 1979). DDC has been used as an anti-
viral agent because of it's ability to bind zinc-dependent 
gene products essential for viral replication in vitro 
(Hutchinson, 1985). Recently, it has also been investi-
gated as an immuno-modulatory agent (Hersh et al., 
1993). 
In vitro studies with DDC by Trombetta et al. 
(1988) have attributed toxicity to the overwhelming in-
flux of copper (greater than a 400 % increase) in treated 
cells. DDC alters copper homeostasis by it's potent 
chelating ability. The bis-(DDC)- copper complex has 
been shown to redistribute copper to the central nervous 
system (Johansson and Stankiewicz, 1985; Allain and 
Krari, 1991). Copper-induced cytotoxicity may be due 
to this complex binding to cellular macromolecules 
resulting in generation of reactive free radical species 
(Tempel et al., 1985; Allain and Krari, 1991). Cupric 
ions also react with membrane sulfhydryl groups result-
ing in the formation of superoxide radicals that are capa-
ble of initiating lipid peroxidation (Hochstein et al., 
1980). Some of the toxic effects of DDC could be 
explained by this mechanism. 
The astrocyte is an essential modulator of normal 
central nervous system (CNS) activity . In the adult 
CNS, it retains a close functional relationship with 
neurons and plays an important role in neuronal metabo-
lism by maintaining the microenvironment that surrounds 
each neuron (Koestner and Norton, 1991). A ratio of 10 
astrocytes to each neuron is not uncommon in some 
areas of the brain (Koestner and Norton , 1991). 
The astrocyte, like other eukaryotic cells, is depend-
ent upon a highly organized internal structure composed 
of a complex network of filamentous proteins. These 
proteins are classified into three widely distributed fiber 
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systems which, in concert, form the cytoskeleton. There 
is a structural and functional interdependence of these 
fiber systems, and therefore, any disruption may result 
in a variety of cellular changes. Alterations in cyto-
skeletal organization can cause irreparable harm to 
cellular homeostasis . 
The cytoskeleton plays a major role in determination 
of cell shape, cell motility , cellular division, intracellular 
transport, and spatial organization of cellular compo-
nents (Bernal and Stahel, 1985). The principal struc-
tures comprising the cytoskeleton are the microtubules, 
intermediate filaments , microfilaments, and the associ-
ated cytoskeletal proteins (Alberts et al., 1989). The 
major protein of the microtubule system is tubulin. 
Intermediate filaments in astroglia are characterized by 
glial fibrillary acidic protein (GF AP) (Hansson et al., 
1984) and microfilaments are primarily composed of 
actin (Alberts et al., 1989). 
Conditions, which may alter states of polymerization 
or the interaction of different cytoskeletal elements, may 
change cell shape or cause the formation of abnormal 
filamentous aggregates within cells. The latter may be 
the case in Alzheimer's disease or other neurodegenera-
tive diseases where neurofibrillary tangles are found. 
These inclusions cross-react with antibodies directed 
against neurofilament s, microtubule associated proteins 
(MAPs), and vimentin. Other cytoskeletal abnormalities 
include Pick Bodies which cross-react with antibodies di-
rected against neurofilament s and tubulin , Lewy Bodies 
which cross-react with antibodies directed against neuro-
filaments, and Hirano Bodies which react with actin anti-
bodies (Goldman and Yen, 1986). 
The purpose of this study is to investigate the cyto-
toxic effects of diethyldithiocarbamate on cultured astro-
glial cells with respect to cytoskeletal alterations. The 
astroglial model system has been chosen because of ear-
ly in vivo degenerative changes found in astrocytes dur-
ing chronic low dose exposure (Trombetta and Adachi, 
1985). 
Materials and Methods 
Cell culture 
Establishment of Astrocyte Cultures. The astro-
cyte cultures were obtained from the hippocampus of 
Sprague Dawley rat pups, postnatal day one. Cultures 
were grown in Dulbecco 's modified Eagle medium 
(DMEM) containing 4.5 g glucose, glutamine, and 25 
mM HEPES buffer per liter supplemented with 10 % 
fetal bovine serum, 0.1 mg/ml streptomycin, and 100 
u/ml penicillin (complete medium). Cultures were incu-
bated at 37°C in an atmosphere containing 92 % air and 
8 % CO2. The method used yields astrocyte cultures that 
are more than 95 % pure as established by immuno-stain-
DDC and astrocytic cytoskeleton 
ing for glial fibrillary acidic protein (GF AP) , an astro-
cyte-specific marker (Trombetta et al ., 1988). 
Experimental protocol 
For all experiments , an aliquot of the trypsinized re-
suspended cells was removed and counted in a hemo-
cytometer. The cells were plated at equal densities into 
appropriate cultureware (flasks, glass slides or onto 12 
mm round glass coverslips) . Exponentially replicating 
cells of the same passage number were grown to a sub-
confluent monolayer prior to DDC exposure . By 48 
hours after plating , astrocytes contained a well-organized 
cytoskeleton and expressed GFAP. DDC exposure 
began at this time period. In all experiments, the 
responses of DOC-treated cell populations were com-
pared to control cells from the same passage. 
The trihydrate sodium salt of diethyldithiocarbamate 
(DDC) was prepared in complete medium and filter ster-
ilized just prior to use . The cells were exposed for one 
hour to 35 µg/ml DDC (1.5 x 10-4 M) (Trombetta et 
al. , 1988). All cells were then rinsed with one wash of 
Dulbecco ' s phosphate buffered saline (PBS) and refed 
with complete medium . Cell suspensions were then 
plated into flasks or onto coverslips . Control and exper-
imental cultures were harvested at 4, 8, 12, and 24 
hours post treatment. These time period s were selected 
because of specific morphologi c and biochemical charac-
teristics (Trombetta et al ., 1988; Stein and Trombetta , 
1993; Simonian et al. , 1992). 
Immunohistochemistry 
Cells were plated and grown to subconfluency on 
glass Lab-Tek® chamber slides and treated according to 
experimental protocol. The cells were rinsed with Dul-
becco's PBS at 25°C and then washed for 15 seconds at 
25°C with a mixture of0 .1 % Triton X-100 and 0.125% 
glutaraldehyde in Dulbecco 's PBS. The cells were then 
washed with Dulbecco's PBS once and fixed in 0.25 % 
glutaraldehyde for 10 minutes. The chamber slides were 
incubated with heat-inactivated goat serum in Dulbecco 's 
PBS (1:20) for 30 minutes . The goat serum was shaken 
off and the chamber slides were flooded with either di-
lute primary /3-tubulin antibody (1:400) or dilute primary 
glial fibrillary acidic protein antibody (1: 800) and in-
cubated for 1 hour . The slides were washed thoroughly 
in several changes of deionized distilled water to remove 
unbound antibody. Diluted gold-conjugated secondary 
antibody was added to the chambers and incubated for 
1 hour. Slides were washed thoroughly with deionized 
distilled water to remove unbound gold particles . The 
gold labeling was enhanced with silver for visualization. 
Slides were immersed in 0.2 M sodium citrate buffer for 
5 minutes to reduce the pH to 3.5 (this slows down the 
silver enhancement reaction) and then placed in silver 
enhancement solution (Zymed, San Francisco, CA) . 
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The slides were developed for 12 minutes and immersed 
in photographic fixative for 5 minutes . 
Scanning electron microscopy 
Whole cell architecture . Cells were grown to sub-
confluence on 12 mm round cover slips in complete me-
dium and treated according to experimental protocol. 
The cells were fixed with 1.5 % glutaraldehyde in Dul-
becco's PBS for 1 hour at room temperature. Dehydra-
tion was achieved by a series of acetone-water steps by 
gently aspirating off half of the old solution and adding 
new. Coverslips were critically point dried (CPD) in a 
Polaron E 3000 drier using bone dry CO2 as the transi-
tion fluid . The specimens were then cold sputter coated 
with 15 nm of gold using a Polaron E 5100, series II 
coater for 60 seconds set at 2.5 kV . Specimens were 
viewed with a eucentric stage on a Hitachi S-530 
scanning electron microscope (SEM) operated at an 
accelerating voltage of 25 kV. 
Cytoskeletal architecture. Cells were grown to 
subconfluence on 12 mm round cover slips in complete 
medium. The cells were treated as previously described 
and the cytoskeletons prepared for SEM according to the 
method of Bell et al. (1988) . 
Scanning electron microscopy is the method of 
choice to examine the cytoskeleton because the spatial 
distribution of the component parts are readily apparent 
(Bell, 1981). At the end of each specified time period , 
the cells were rinsed twice with calcium-free PBS, pH 
7.4 , at 37°C to remove contaminants. If the calcium in 
the growth medium is not removed by rinsing, micro-
tubules may depolymerize and thus be partially or com-
pletely lost (Bell, 1981). Additionally , serum proteins 
in the media must be removed as they may contaminate 
the extracted cytoskeletons. 
Fixation of the cells prior to lysis was carried out 
with the reversible protein cross-linker dithiobis(succin-
imidyl propionate) (DSP) from Pierce (Rockford, IL). 
The cells were cross-linked to the substratum with DSP 
dissolved in PBS supplied with 1 g/1 glucose at 37°C for 
10 minutes . A stock solution of 20 mg/ml DSP was 
prepared in dimethylsulfoxide (Eastman Kodak Co., 
Rochester , NY). This solution was diluted 1:100 in the 
appropriate buffer immediately before use. The purpose 
of prefixing with DSP was to stabilize the cytoskeleton 
in order to help it withstand the rigors of the extraction 
procedure (Bell, 1981). Prefixation also markedly 
improves the quantitative retention of cytoskeletal 
structures. 
Subsequent to initial cross-linking, the cells were 
extracted with 0.5% Triton X-100 in microtubule stabi-
lizing buffer (MSB) containing DSP and maintained at 
37°C for 10 minutes. MSB consists of 1 mM ethylene 
glycolbis(2-aminoethylether)-N ,N ,N' ,N'-tetraaceticacid 
Mary F. McManus and Louis D. Trombetta 
(EGT A), 4 % polyethylene glycol 6000 (PEG 6000), 100 
mM pip.erazine-N ,N' -bis(2-e thane-sulfonicacid) (PIPES) 
and 0.0015% phenol red (Eastman Kodak, Rochester, 
NY), pH 6.9. Cells were extracted further with two 
washes of 0.5% Triton X-100 in MSB for 5 minutes 
each. They were exposed to a fourth detergent wash 
containing 2.5 % glutaraldehyde (GA) for 30 minutes at 
25°C. Cytoskeletons were post-fixed with 2.5 % GA in 
a rinsing buffer (RB) for 12 hours at 4 °C . The RB 
consisted of 0.1 M sucrose and 0.1 M cacodylate buffer, 
pH 7.2. The cytoskeletons were rinsed three times with 
RB for 5 minutes each and placed into a distilled water 
rinse. Dehydration was achieved by a series of acetone-
water steps by gently aspirating off half of the old solu-
tion and adding new. Subsequently, the cytoskeletons 
were dehydrated, critical point dried, sputter coated, and 
viewed as described above. 
SOS-PAGE of cytoskeletal extracts 
Cells were grown in 75 cm2 flasks and treated ac-
cording to the protocol described above. The cells from 
each experiment were harvested and protein extracted 
according to the method of Bell et al. (1988). This pro-
cedure is detailed above in the SEM section up to the 
second extraction/fixation step. The flasks were then 
gently rinsed twice with MSB at 37°C. The cells were 
fully extracted with 0.5% Triton X-100 in MSB for 5 
minutes with gentle rocking . This last step was followed 
by two additional washes of MSB. The cells were then 
scraped down in the final MSB wash to be pooled and 
centrifuged . The resulting pellet was suspended in 1 or 
2 ml of MSB and stored in a cryovial at -70 °C for 
future use. When removed from the freezer, the sus-
pension was micro-homogenized under cold conditions. 
Aliquots of samples were removed from the stock 
and diluted in tracking buffer containing 0.125 M Tris-
Cl, pH 6.8, 4% SOS, 20% glycerol, and 10% 2-mer-
captoethanol. Samples were run on SDS-polyacrylamide 
gels. The gels were prepared according to the Laemmli 
(1970) system with a 10% slab and a 4% stacking gel. 
These gels were prepared fresh for each run, which was 
carried out in running buffer at room temperature, con-
sisting of 0.1 % SDS-0.025 M Tris-glycine buffer pH 
8.8. All electrophoreses were performed in duplicate on 
the SE 250 Mighty Small II (Hoefer Scientific Instru-
ments, San Francisco, CA). Gels were stained over-
night with 0.125 % Coomassie Brilliant Blue R in 50 % 
methanol and 10 % acetic acid. They were destained for 
1 hour in 50% methanol and 10% acetic acid, and then 
placed in 7 % acetic acid and 5 % methanol. 
Protein concentrations for treated and control sam-
ples were all normalized before loading into sample 
wells. Rainbow markers (Amersham, Arlington 
Heights, IL) with a range of molecular weights from 200 
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Figure l. Phase contrast micrograph of control rat 
astrocytes in culture. The peripheral regions of the cells 
(solid arrows) are more translucent than their perinuclear 
regions (open arrows). 
Figure 2. Electron micrograph of a control astrocyte. 
Note that in the peripheral region rod-like structures can 
be seen under the plasmalemma. These structures may 
represent the underlying cytoskeleton. Sometimes in the 
perinuclear region of the cell a punctate cell surface 
could be seen. These openings did not appear artifactual 
since they showed a continuous cell membrane. Nucleus 
(N); Perinuclear region (NR); Peripheral region (PR). 
Figure 3. Light micrograph of a control astrocyte im-
munohistochemically stained with colloidal gold for t,-tu-
bulin. Notice the ray-like projection from the juxtanu-
clear region. This region probably represents the region 
of the centrosome. 
Figure 4. Light micrograph of a control astrocyte im-
munohistochemically stained for t,-tubulin. Note that the 
microtubules radiate from the center of the cell; tum and 
run parallel to the cell perimeter . 
Figure 5. Light micrograph of a control astrocyte im-
munohistochemically stained for GFAP. Note that the 
fibers lack polarity and appear more randomly distrib-
uted than those composed of tubulin. 
Figure 6. Light micrograph of a control astrocyte im-
munohistochemically stained for GFAP. Notice the fine 
interlacing network of fibers extending into the periphery 
of the cell. 
to 14.3 kD were used. A second set of markers in the 
high molecular weight range were also used (Sigma, St. 
Louis, MO). The molecular weights of these markers 
ranged from 205 to 29 kD. 
Western blot analysis 
Upon completion of the PAGE electrophoresis, one 
gel was immediately placed in the Coomassie blue stain 
while the other was transferred to a 0.45 µm nitrocellu-
lose using a TE 22 Mighty Small~ Transphor unit 
(Hoefer Scientific Instruments). The alkaline phospha-
tase immunoblot kit from Zymed (San Francisco, CA) 
containing a biotinylated anti-mouse IgG conjugate was 
used for the detection of antigen-antibody binding. The 
three primary antibodies that were used for protein anal-
ysis were anti-{1-tubulin, anti-GF AP, and anti-actin. All 
primary antibodies were diluted in PBS containing 1 % 
BSA. Monoclonal anti-{1-tubulin (Sigma) was used at 
the recommended dilution of 1:400, monoclonal glial 
fibrillary acidic protein (Sigma) was diluted 1 :200 and 
monoclonal anti-actin (Sigma) was diluted 1:600. All 
blots were incubated with chromagen and preserved with 
a 10% solution of glycerol in water . 
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Figure 7 (above) . Electron micrograph of a cytoskeletal preparation of a control astrocyte. Note the dense actin core 
(arrow) next to the nucleus (N) and cytoskeletal elements radiating from this area. Marginal banding can be seen at 
the periphery of the cell (open arrow). Perinuclear region (NR); Peripheral region (PR) . 
Figure 8. Electron micrograph of a control astrocyte showing the parallel arrangement of cytoskeletal elements at the 
periphery of the cell. Note the cross-bridges between the filamentous structures (arrows). 
Figure 9. Electron micrograph of a control astrocyte showing an intricate network of interlacing weave-like cytoskeletal 
structures close to the perinuclear region . 
Figure 10. Phase contrast micrograph of an astrocyte 4 hours after treatment with 35 µ/ml of media of DDC. Note 
granular and vacuolar nature of the perinuclear area (arrow) and the small distorted processes radiating from the cell 
(arrow head). 
Figure 11. Light micrograph of DOC-treated cells (35 µg /ml) 4 hours after treatment stained immunohistochemically 
for t1-tubulin. Notice that the cells have decreased staining especially in the juxtanuclear region. 
Figure 12. Light micrograph of DOC-treated cells (35 µg/ml) 4 hours after treatment stained immunohistochemically 
for GFAP. Note that the filament are disrupted and appear as granulated material. 
Figure 13. Whole mount electron micrograph of an astrocyte 4 hours after treatment with 35 µg/ml of media of DOC. 
Note the raised nuclear region (N) and the irregularly contoured cytoplasmic regions. 
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Figure 14. Electron micrograph of a cytoskeletal preparation of an astrocyte 4 hours after treatment with 35 µglml 
of media of DDC . Notice the presence of condensation products (open arrows) and the raised nucleus (N) . Note that 
the actin sheets (arrow heads) are still present. 
Results 
Rat hippocampal astrocytes grown in vitro are pleio-
morphic appearing fusiform, stellate, round or oval (Fig. 
1). These cells appeared to be composed of two regions 
(Figs. 1 and 2) regardless of cell shape; the central peri-
nuclear region (NR) encompassing the nucleus and a thin 
almost translucent, lacy peripheral region (PR). By light 
microscopy, this peripheral region may be erroneously 
interpreted to be matrix and not cellular in nature . 
Immunolabelling of tubulin with gold showed micro-
tubules radiating like spokes from a wheel from the cen-
tral nuclear region to the cell periphery (Fig. 3). The 
density of microtubules decreased as they migrated away 
from the central region. Microtubules that extended to 
the edge of the cell often turned and ran parallel to the 
cell perimeter, resembling a marginal band (Fig. 4). 
lmmunolabelling of glial fibrillary acidic protein 
(GF AP) with gold showed a somewhat similar arrange-
ment of the filaments as the tubules (Fig. 5). One 
exception is that as they extend toward the periphery of 
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the cell , the GF AP containing filaments formed an inter-
twining network (Fig . 6) . 
Scanning electron microscopy of whole mount prep-
arations showed a similar morphological arrangement to 
what was seen by light microscopy. The cell was di-
vided into a central endoplasmic region containing the 
nucleus (NR) and a much flatter and thinner peripheral 
exoplasmic region (PR) (Fig. 2). The nuclear region 
displayed an irregular contour covering a flattened or 
slightly raised nucleus. The surface of the perinuclear 
area appeared irregular, containing many pits and de-
pressions (Fig. 2). These pits do not appear to be 
artifactual since no disruptions in the cell membrane are 
seen. Fusiformed shaped cells appeared to have the 
largest nuclear to cytoplasmic ratio. Peripheral regions 
appeared smoother, and much thinner. Elongated, thin, 
raised structures were seen under the plasmalemma and 
represent underlying cytoskeletal components (Fig. 2). 
Cytoskeletal preparations of control cells at all times 
appeared similar (Fig 7) . 
DDC and astrocytic cytoskeleton 
Figure 15. Electron micrograph of a cytoskeletal preparation of an astrocyte 8 hours after treatment with 35 µg/ml 
of media of DDC . Note that these cells show little or no filamentous structures and numerou s condensation s product s 
(arrows) . 
Cytoskeletal preparations of astrocytes revealed a 
complex network of interlacing fibers and sheets of 
structural elements . These structures appeared as bun-
dles and sometimes as thinner 25 run and 40 nm fibers. 
Since the thickness of deposited gold was 15 nm , the 25 
nm and 40 nm fibers may represent intermediate fila-
ments and microtubules . The cortices of these cells , 
particularly in the perinuclear region, were composed of 
a dense mat of microfilament s (actin). Individual micro-
filaments were not resolved because of their size (5 nm) 
and dense packing. Higher magnification showed these 
actin sheets overlying larger filamentous structures. In 
the peripheral region, the actin sheets were almost ab-
sent and the larger filamentous structures were easily 
seen. A highly intricate cytoskeleton, appearing as a 
weave-like pattern, was observed (Figs. 8 and 9) . Bun-
dles of fibers were seen radiating from the central por-
tion of the cell and eventually projecting as a web-like 
marginal band at its extreme periphery (Fig. 7) . Cross 
bridges were seen connecting these fibers . 
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DDC treatment (35 µg/ml) showed, by 4 hours, the 
presence of small granules and vacuoles in the peri-
nuclear region (Fig . 10). A progressive disruption of 
the microtubules was seen. lmmunohistochemical stain-
ing with /'.1-tubulin showed fragmented, small particulate 
immuno-stained material (Fig. 11). Degeneration pro-
gressed rapidly (from 4 to 24 hours) , eventually leading 
to a total loss of cytoskeletal elements . Large regions of 
the cell either did not stain at all (particularly in the 
perinuclear region) or microtubular material appeared as 
a condensed reaction product (Fig. 11 ). GFAP was 
also altered by DDC treatment. Alterations often 
appeared as disruption of these filaments into aggregates 
of reaction product (Fig. 12). 
Scanning electron micrographs of whole mount 
preparations of astrocytes, after 4 and 8 hours post-DDC 
treatment, showed a highly irregular cell surface and an 
elevated nucleus (Fig . 13). No cytoskeletal elements 
were seen after the 12 hours time period. Scanning 
electron microscopy at 24 hours, showed cells similar to 
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Figure 16. SDS-PAGE electrophoresis of cytoskeletal 
preparations at 4, 8 and 12 hours post treatment with 35 
µglml of media of DDC . Lane 1: standards (kD) ; Lane 
2: control at 4 hours; Lane 3: DDC treatment at 4 
hours ; Lane 4 : control at 8 hour s; Lane 5: DOC-treat-
ment at 8 hours; Lane 6: control at 12 hours ; and Lane 
7: DDC at 12 hours . Arrow indicates GFAP region . 
what was seen at 12 hours except that there was a com-
plete loss of peripheral cytopla sm. Cytoskeletal prepara-
tions at 4 hours showed numerous condensation products 
dispersed through out the cell. They were also seen 
covering the nucleus. These condensation products 
appeared irregular in shape and of various sizes. Actin 
sheets were visible but discrete filamentou s structures 
were absent (Fig. 14). 
By 8 hours, cytoskeletal preparation s showed that 
both the central and peripheral regions were severely 
disrupted. Condensation products and clumping of cyto-
skeletal elements were observed throughout the cell . 
Actin filaments had irregular contours and the cell 
periphery was completely disorganized . Filamentou s 
structures were rarely observed (Fig. 15). 
Electrophoresis 
The electrophoretic pattern of the treatment groups 
at 4, 8, and 12 hours after DDC treatment revealed a 
decreased staining in the 50 kD range (Fig . 16). This is 
approximately the range for the GFAP intermediate fila-
ment protein . Because only living adherent cells were 
studied, very small amounts of protein were obtained 
from the treatment groups in the latter time periods . All 
wells were adjusted at each time period with the same 
quantity of cytoskeletal protein. Western blots at 4, 8 
12 and 24 hours all appeared similar. Localization of 
tubulin revealed a blotchy appearance of the tubulin band 
in the treated cells verses the control astrocytes. The 
blotchy material appeared heavier in weight and dragged 
behind the main tubulin band. GF AP was reduced in 
the treated cells. Actin, on the other hand, was heavily 
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Figure 17. Western blots of representative cytoskeletal 
proteins post treatment with 35 µglml of media of DDC . 
Lanes 1 and 2 represent immunoblots directed against 
,6-tubulin. Lane 1 is control protein and lane 2 is 
prot ein from treated cells . Lanes 3 and 4 are immuno -
blots directed against GF AP . Lane 3 is control and lane 
4 is treated . Lanes 5 and 6 are immunoblot s directed 
against actin . Lane 5 is control and lane 6 is treated. 
The numbers at the left are molecular wights in kD . 
Note the aberrant tubulin band in the treated group and 
the decreased in GF AP in the treated group . The actin 
bands appear similar in both control and treated groups. 
These results were similar for all time periods . 
stained in all cell types whether found in treated or 
control cells (Fig . 17). 
Discussion 
This is the first time DOC-induced cytoskeletal al-
terations have been documented in the astroglial cell cul-
ture system. Previou s studies have all utilized either 
animal, cell free in vitro systems or tissue culture tech-
niques using other cell types . None of these investiga-
tions used time course studie s specifically targeting the 
cytoskeleton or examined the cytoskeleton using SEM. 
Recent evidence suggests that the astrocyte is fre-
quently the initial target for toxic insult in the CNS. 
Any alterations in astrocytic function will ultimately lead 
to neuronal injury due to the close functional relationship 
between these cell types (Aschner and Kimelberg, 1991; 
Koestner and Norton, 1991) . DOC-induced neuronal 
degeneration , therefore, may be due to both direct cyto-
toxic effects and indirect effects secondary to astroglial 
insult. 
Some of the dithiocarbamates have been reported to 
produce neuropathologic changes in the hippocampus. 
Trombetta and Adachi (1985) noted abnormal intracellu-
lar tubular material in the hippocampus after 18 months 
of treatment with the drug disulfiram (an oxidized parent 
DDC and astrocytic cytoskeleton 
compound which is metabolically interconvertible with 
DDC) (Simonian et al., 1992). 
The pathogenesis of many neurotoxic substances is 
often associated with profound disorganization of cyto-
skeletal structures with loss or accumulation of the indi-
vidual elements. Intermediate filaments are of special 
interest because of their tendency to form dense aggre-
gates in several experimental and human toxic neuro-
pathies (Bilbao et al., 1984). Dithiocarbamates have 
been shown to cause toxic injury to neurons with effects 
seen in the perikaryon and the axon resulting in abnor-
mal accumulation of microtubules, loss and/or accumula-
tion of neurofilaments, and cytoplasmic lipid debris 
(Trombetta and Adachi, 1985). DOC-induced altera-
tions of filamentous proteins have been documented in 
several other in vivo studies (Kim and Rizzuto, 1975; 
Ueno et al., 1977; Ansbacher et al., 1982, Bilbao, 
1984; Lehto et al., 1984). In the present study, similar 
alterations of the intermediate filaments and microtubules 
of the astrocyte have been found. A progressive loss of 
organized cellular architecture associated with loss of in-
termediate filaments and altered microtubular structures 
was seen. 
Chronic dithiocarbamate administration has been 
shown to produce a distal neurofilamentous axonopathy 
(Ansbacher et al., 1982). The axonal swellings consist-
ed of masses of neurofilaments and various distorted 
membranous organelles. Bilbao et al. (1984) also exam-
ined a filamentous axonopathy induced by disulfiram 
which displayed axonal enlargements due to the accumu-
lation of whorled filaments. Dispersed among these fila-
ments were microtubules and mitochondria . 
Potchoo et al. (1986) studied the dose-dependent 
inhibition of microtubule formation by disulfiram in a 
cell free system. The rnicrotubules showed a drastic de-
crease in number and length with a decreased rate of 
polymerization. They suggest that this inhibition is cor-
related to the direct blockade of sulfhydryl groups in 
rnicrotubules by disulfiram. 
Lehto et al. (1984) studied the effects of disulfiram 
and some other dithiocarbamates on the cytoskeleton of 
neuronal cells in vivo and in vitro. Disulfiram caused 
rounding up of cells and an accumulation of tubulin in 
discrete clumps often seen as cellular protrusions. By 
electron microscopy, in vivo findings included a slight 
decrease in the filament density and a clear decrease in 
the number of rnicrotubules (1 and 3 week studies). The 
dithiocarbamate fungicides ferbam and thiram (which are 
metabolized to DDC) had a pronounced effect on the 
morphology and structure of both rnicrotubules and 
intermediate filaments. The authors suggested further 
studies into whether metal complexes with some dithio-
carbamates contribute to the adverse effects on the cyto-
skeleton. 
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The hippocampus is also known to accumulate 
metals, thereby acting as a primary metal sink in the 
CNS (Danscher et al., 1976). Histochemical findings 
indicate that the excessive uptake of copper results in 
accumulation in both the glial cells and pyramidal cells 
(Szerdahelyi and Kasa, 1987). Lakomaa et al. (1982) 
examined several brain regions of DOC-treated rats. 
Chronic dosing over a four week period resulted in ele-
vated copper concentrations, particularly with respect to 
the hippocampal region (44.2%) and the brain stem 
(55.2 % ). Overall, the data demonstrated a significant 
degree of tissue selectivity for copper disposition. This 
may be related to its aggregation in specific cell types. 
Therefore, it is reasonable to examine the hippocampal 
astrocyte due to the well-documented effects of DDC 
and copper in vivo within this region. 
O'Shea and Kaufman (1980) examined the effects of 
copper on rnicrotubular degeneration in neuroepithelial 
cells. Ultrastructurally, these cells showed a reduction 
in the number of rnicrotubules and/or an increase in mi-
crotubular remnants. Often, the microtubules appeared 
to have a fuzzy, rather than a sharply-defined, outline 
and occasionally gaps were present along their length. 
Some of the toxic effects of DDC may be due to the 
preferential redistribution of metals to the CNS by the 
highly lipophilic DDC metal (copper) complex (Miller, 
1982; Andersen and Nielsen, 1989). 
Microtubule assembly and disassembly is dependent 
on the concentrations of divalent cations present 
(Weisenberg, 1972). Metal-induced inclusions may rep-
resent the breakdown products of microtubules them-
selves (Gaskin and Shelanski, 1976). O'Shea and 
Kaufman (1980) suggest that an elevation in the intra-
cellular concentration of microtubular precursor ele-
ments, following rnicrotubular depolymerization, may 
lead to their precipitation and consequent appearance in 
this aggregated form. Therefore, protein synthesis does 
not appear to be crucial for this aggregation to take 
place (O'Shea and Kaufman, 1980). 
In this study, SEM data demonstrates that micro-
tubular and intermediate filament structure is altered 
after DDC exposure . The DOC-treated cells showed 
accumulation of condensation products with extensive 
disruption of the cytoskeletal architecture over time. 
SEM also shows loss of filaments and fused cytoskeletal 
condensate. The actin cortex appeared fairly unscathed 
except during the later stages of DDC insult. 
Western blots showed changes in the mobility of the 
,6-tubulin protein and a decrease in GF AP in the DDC-
treated cells at all time periods. Little or no alterations 
of actin were seen. These results suggest that DDC may 
selectively alter microtubules and intermediate filaments. 
The toxic effects of DDC are multietiological with 
a complex pathogenesis and multiple aberrant mani-
Mary F. McManus and Louis D. Trombetta 
festations . These findings must be taken into account 
when researching the role of the dithiocarbamate s in any 
clinical or environmental application. 
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Discussion with Reviewers 
M. Lindroth: How was the concentration of 35 µM 
DDC chosen? 
Authors: The concentration of 35µM DDC was chosen 
from previous studies on the toxicity of DDC on astro-
cytes in culture and resulting viability curves (Trombetta 
et al., 1988). Viability was determined using trypan 
blue exclusion. This dose approximates the LD 50. 
F. Barile: It has been suggested that the toxicity of 
DDC may be mediated in part by the formation of su-
peroxide radicals through cupric ion interaction with 
membrane sulthydryl groups . Could this represent a 
universal phenomenon resulting in lipid peroxidation, 
such as that seen in paraquat toxicity? 
Authors: DDC causes lipid peroxidation directly related 
to copper concentration (Delmaestro and Trombetta, 
1995). In addition, cytoskeletal architecture is 
dependent on its sulthydryl status . Any interruption of 
this status can result in its depolymerization (Trombetta 
and Kromidas, 1992). 
F. Barile : How does the changes in the electrophoretic 
patterns of tubulin and GF AP observed between control 
and DDC treatment explain the morphological differ-
ences seen in the micrographs? 
Authors : Although electrophoretic patterns can give 
some indication of altered mobility and differences in 
protein concentration, they do not clearly indicate what 
these changes represent in terms of cytoskeletal architec-
ture. Tubulin and intermediate protein may be present 
but not arranged in the proper pattern or architecture. 
The condensation products seen in cytoskeletal prepara-
tions of treated astrocytes are cytoskeletal proteins but 
the SEM shows obvious alterations to cellular architec-
ture. 
M. Malecki: Considering your results and those from 
the work by Dr. Nedergaard (Science 263: 1768; 1994), 
can you comment on the effects of DDC on astrocyte/ 
neuron interactions in vivo? 
Authors: There is no doubt that astrocyte/neuron inter-
actions have to be studied more closely . Previous work 
in our laboratory (Trombetta and Adachi, 1985) indi-
cated that, in an in vivo study, the rat astrocyte was 
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altered by the administration of disulfiram (the parent 
compound ofDDC) prior to any change seen in neurons. 
Nadergaard and others have shown an intimate physio-
logical relationship between these two cell types . This 
interdependence may extend beyond normal function and 
may also involve relationships resulting from toxic insult 
to one cell type or the other. 
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